Mayo Clinic and Boston Scientific Corp. have launched a new venture in Rochester, Minnesota to accelerate the development of medical technology and new minimally invasive treatments for many health conditions that impede quality and longevity of life.
Known as Motion Medical, the accelerator will have its research facilities in One Discovery Square, the bioscience center in the Discovery Square research district. Both parties have committed millions of dollars over three years to develop and bring new solutions to the market to address unmet medical needs.
"Mayo Clinic is committed to accelerating the pace of discoveries to bring new technologies and treatments to patients faster," says Gianrico Farrugia, M.D., president and CEO of Mayo Clinic. "This collaboration and others like it will continue to strengthen Rochester and Minnesota as a biomedical innovation and economic powerhouse."
"This collaboration between Mayo Clinic and Boston Scientific builds on our experience working together to support the shared goal of advancing patient-centered innovation," says Mike Mahoney, chairman and CEO, Boston Scientific. "This approach combines the unique strengths of our two organizations, and we look forward to working together to solve complex health care challenges."